U.S. Markets open in 46 mins.

Array BioPharma Inc. (ARRY)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
11.29+0.47 (+4.34%)
At close: 4:00PM EDT

11.30 +0.01 (0.09%)
Pre-Market: 8:23AM EDT

People also watch
Full screen
Previous Close10.82
Bid11.01 x 200
Ask11.39 x 400
Day's Range10.56 - 11.37
52 Week Range3.49 - 13.40
Avg. Volume4,078,851
Market Cap2.17B
PE Ratio (TTM)-15.68
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com4 days ago

    Mirati Skyrockets On Positive Data - Biotech Movers

    The San Diego firm is scheduled to present positive preliminary data for two clinical studies of sitravatinib in non-small cell lung cancer at a symposium in Chicago on Friday.

  • American City Business Journals5 days ago

    Colorado biotech plans $200 million stock offering

    A Boulder biotech said it's commenced an underwritten public offering of about $200 million of its stock. Array BioPharma Inc. said it's begun an offering of $175 million of shares of its common stock, and it's giving underwriters the option to buy up to an additional $26 million in shares. In the SEC filing, Array officials said the company's stock price will probably not remain stable.

  • 24/7 Wall St.5 days ago

    Array BioPharma Slides on Secondary Offering

    Array BioPharma saw its shares turn negative early on Thursday after the firm announced a secondary offering.